71 related articles for article (PubMed ID: 21541481)
1. Nimodipine as a modulator of resistance to doxorubicin in human colon-adenocarcinoma cells.
Bearzatto A; Saino A; Zaffaroni N; Costa A; Santi S
Int J Oncol; 1996 Jul; 9(1):57-63. PubMed ID: 21541481
[TBL] [Abstract][Full Text] [Related]
2. Reversal of adriamycin resistance by recombinant alpha-interferon in multidrug-resistant human colon carcinoma LoVo-doxorubicin cells.
Scala S; Pacelli R; Iaffaioli RV; Normanno N; Pepe S; Frasci G; Genua G; Tsuruo T; Tagliaferri P; Bianco AR
Cancer Res; 1991 Sep; 51(18):4898-902. PubMed ID: 1893380
[TBL] [Abstract][Full Text] [Related]
3. Flunarizine as a modulator of doxorubicin resistance in human colon-adenocarcinoma cells.
Silvestrini R; Zaffaroni N; Costa A; Orlandi L; Villa R; Hendriks HR
Int J Cancer; 1993 Oct; 55(4):636-9. PubMed ID: 8406992
[TBL] [Abstract][Full Text] [Related]
4. Intracellular doxorubicin concentrations and drug-induced DNA damage in a human colon adenocarcinoma cell line and in a drug-resistant subline.
Broggini M; Grandi M; Ubezio P; Geroni C; Giuliani FC; D'Incalci M
Biochem Pharmacol; 1988 Dec; 37(23):4423-31. PubMed ID: 3202888
[TBL] [Abstract][Full Text] [Related]
5. Susceptibility of chemoresistant murine and human tumor cells to lysis by interleukin 2-activated lymphocytes.
Gambacorti-Passerini C; Rivoltini L; Supino R; Rodolfo M; Radrizzani M; Fossati G; Parmiani G
Cancer Res; 1988 May; 48(9):2372-6. PubMed ID: 3258541
[TBL] [Abstract][Full Text] [Related]
6. Pharmacological and biological evidence for differing mechanisms of doxorubicin resistance in two human tumor cell lines.
Slovak ML; Hoeltge GA; Dalton WS; Trent JM
Cancer Res; 1988 May; 48(10):2793-7. PubMed ID: 2896069
[TBL] [Abstract][Full Text] [Related]
7. Multidrug resistance reversal and apoptosis induction in human colon cancer cells by some flavonoids present in citrus plants.
Wesołowska O; Wiśniewski J; Sroda-Pomianek K; Bielawska-Pohl A; Paprocka M; Duś D; Duarte N; Ferreira MJ; Michalak K
J Nat Prod; 2012 Nov; 75(11):1896-902. PubMed ID: 23137376
[TBL] [Abstract][Full Text] [Related]
8. Modulation of multidrug resistance by verapamil or mdr1 anti-sense oligodeoxynucleotide does not change the high susceptibility to lymphokine-activated killers in mdr-resistant human carcinoma (LoVo) line.
Rivoltini L; Colombo MP; Supino R; Ballinari D; Tsuruo T; Parmiani G
Int J Cancer; 1990 Oct; 46(4):727-32. PubMed ID: 1976601
[TBL] [Abstract][Full Text] [Related]
9. Doxorubicin induces the acetylation of histone H1 in a human colon cancer cell line (LoVo/DX) selected for resistance to the drug, but not in the sensitive parental line (LoVo).
Mannironi C; D'Incalci M
Biochem Biophys Res Commun; 1988 Sep; 155(3):1221-9. PubMed ID: 3178805
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of proliferation by c-myb antisense oligodeoxynucleotides in colon adenocarcinoma cell lines that express c-myb.
Melani C; Rivoltini L; Parmiani G; Calabretta B; Colombo MP
Cancer Res; 1991 Jun; 51(11):2897-901. PubMed ID: 2032228
[TBL] [Abstract][Full Text] [Related]
11. DNA damage and cytotoxicity of mitoxantrone and doxorubicin in doxorubicin-sensitive and -resistant human colon carcinoma cells.
Capolongo L; Belvedere G; D'Incalci M
Cancer Chemother Pharmacol; 1990; 25(6):430-4. PubMed ID: 2311171
[TBL] [Abstract][Full Text] [Related]
12. Cytoplasmic membrane cholesterol and doxorubicin cytotoxicity in drug-sensitive and multidrug-resistant human ovarian cancer cells.
Mazzoni A; Trave F
Oncol Res; 1993; 5(2):75-82. PubMed ID: 8364256
[TBL] [Abstract][Full Text] [Related]
13. A comparative study of the effects of anthracycline derivatives on a human adenocarcinoma cell line (LoVo) grown as a monolayer and as spheroids.
Soranzo C; Ingrosso A
Anticancer Res; 1988; 8(3):369-73. PubMed ID: 3389741
[TBL] [Abstract][Full Text] [Related]
14. Hyperthermia enhances cytotoxicity of amine oxidase and spermine on drug-resistant LoVo colon adenocarcinoma cells.
Agostinelli E; Belli F; Dalla Vedova L; Marra M; Crateri P; Arancia G
Int J Oncol; 2006 Jun; 28(6):1543-53. PubMed ID: 16685455
[TBL] [Abstract][Full Text] [Related]
15. Cytotoxic effects of four aescin types on human colon adenocarcinoma cell lines.
Seweryn E; Gleńsk M; Sroda-Pomianek K; Ceremuga I; Wlodarczyk M; Gamian A
Nat Prod Commun; 2014 Mar; 9(3):387-90. PubMed ID: 24689224
[TBL] [Abstract][Full Text] [Related]
16. Mitochondrial alterations induced by serum amine oxidase and spermine on human multidrug resistant tumor cells.
Arancia G; Calcabrini A; Marra M; Crateri P; Artico M; Martone A; Martelli F; Agostinelli E
Amino Acids; 2004 Jun; 26(3):273-82. PubMed ID: 15221508
[TBL] [Abstract][Full Text] [Related]
17. Electroporation adopting trains of biphasic pulses enhances in vitro and in vivo the cytotoxic effect of doxorubicin on multidrug resistant colon adenocarcinoma cells (LoVo).
Meschini S; Condello M; Lista P; Vincenzi B; Baldi A; Citro G; Arancia G; Spugnini EP
Eur J Cancer; 2012 Sep; 48(14):2236-43. PubMed ID: 22240284
[TBL] [Abstract][Full Text] [Related]
18. Enzymatic oxidation products of spermine induce greater cytotoxic effects on human multidrug-resistant colon carcinoma cells (LoVo) than on their wild-type counterparts.
Calcabrini A; Arancia G; Marra M; Crateri P; Befani O; Martone A; Agostinelli E
Int J Cancer; 2002 May; 99(1):43-52. PubMed ID: 11948490
[TBL] [Abstract][Full Text] [Related]
19. Effect of pO2 on antitumor drug cytotoxicity on MDR and non-MDR variants selected from the LoVo metastatic colon carcinoma cell line.
Lelong-Rebel I; Brisson C; Fabre M; Bergerat JP; Rebel G
Anticancer Res; 2008; 28(1A):55-68. PubMed ID: 18383825
[TBL] [Abstract][Full Text] [Related]
20. A comparison of the modulation of antiblastics cytotoxicity by verapamil and dipyridamole in a human colon carcinoma cell line.
Berti E; Carrara M; Ragazzi E; D'Ancona S; Berti T
Int J Oncol; 1999 Jul; 15(1):155-60. PubMed ID: 10375609
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
